A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma
Conditions: Classical Hodgkin Lymphoma; Non-Hodgkin Lymphoma Intervention: Biological: GEN3017 Sponsor: Genmab Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials